Sylvia Kehlenbrink is an Endocrinologist and Director of Global Endocrinology at Brigham and Women’s Hospital, Part-time Instructor at Harvard Medical School, and Founder and Director of the Diabetes in Humanitarian Crises Program at the Harvard Humanitarian Initiative. She graduated from medical school at the Charité-Universitätsmedizin in Berlin, Germany, completed her residency training in Social Internal Medicine at Montefiore Medical Center in New York and her fellowship in Endocrinology at Brigham and Women’s Hospital in Boston. Her research focus has been on diabetes care in humanitarian settings and improving insulin access in low and middle-income settings. In her current position, she leads the Humanitarian NCD InTeragency study in Emergencies and Disasters (UNITED) study which consists of six leading international humanitarian organizations and has the goal of improving diabetes care in humanitarian contexts through collaborative, practice-based research. She organized the inaugural Symposium on Diabetes in Humanitarian Crises at Harvard University in April 2019 which convened over 100 leaders in global health to discuss the immediate needs and barriers to tackling diabetes in humanitarian crises, and adopt a unified, action-oriented agenda. The meeting resulted in the Boston Declaration which was published in The Lancet Diabetes & Endocrinology and outlines four key target areas that the 64 signatories are seeking to address over the next three years. She is now leading the newly formed International Alliance for Diabetes Action (IADA) which seeks to address the targets in the Boston Declaration.